+ 2.69
+ 1.88%

Why BioNano Genomics Traded Higher Today

May 13, 2021 5:18 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

BioNano Genomics Inc (NASDAQ:BNGO) shares traded higher by 6.9% to $4.41 after the company reported better-than-expected first-quarter sales results.

Bionano Genomics reported quarterly sales of $3.2 million, which beat the analyst consensus estimate of $2.9 million.

See also: How to Buy Bionano Genomics Inc. (BNGO) Stock

Bionano Genomics is a life sciences instrumentation company in the genome analysis space. It's engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

Bionano Runs Higher Following CCO Appointment

Bionano Genomics Inc. (NASDAQ: BNGO) shares climbed higher Monday after the company appointed Jason Priar as its Chief Commercial Officer. read more

Is Reddit Favorite BioNano Genomics About To Nosedive?

BioNano Genomics (NASDAQ: BNGO) is testing an important support at the $5 level. If this support breaks, shares could make a rapid and large move lower. There’s an old saying on Wall Street that “gaps refill." It’s true and it could happen with BioNano. read more

2 Biopharma Stocks That Look Ready For A Bullish Reversal

Ocugen Inc. (NASDAQ: OCGN) and Bionano Inc. (NASDAQ: BNGO) are two biopharma stocks moving higher Wedn read more